EUVIMEDEUVIMED entdecken
Crossref

Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease

Oriana Mandolfo, Aiyin Liao, Esha Singh, Claire O'leary, Rebecca J Holley, Brian W Bigger iD

Human Gene Therapy · 2024

DOI: 10.1089/hum.2023.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Gene Therapy, 2024. Verfasst von Oriana Mandolfo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manch…. Hauptthemen laut MEDLINE: Mucopolysaccharidosis II, Medically Unexplained Symptoms, Iduronate Sulfatase, Nervous System Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mucopolysaccharidosis type II (MPSII) is a rare pediatric X-linked lysosomal storage disease, caused by heterogeneous mutations in the iduronate-2-sulfatase ( IDS ) gene, which result in accumulation of heparan sulfate (HS) and dermatan sulfate within cells. This leads to severe skeletal abnormalities, hepatosplenomegaly, and cognitive deterioration. The progressive nature of the disease is a huge obstacle to achieve full neurological correction. Although current therapies can only treat somatic symptoms, a lentivirus-based hematopoietic stem cell gene therapy (HSCGT) approach has recently achieved improved central nervous system (CNS) neuropathology in the MPSII mouse model following transplant at 2 months of age. In this study, we evaluate neuropathology progression in 2-, 4- and 9-month-old MPSII mice, and using the same HSCGT strategy, we investigated somatic and neurological disease attenuation following treatment at 4 months of age. Our results showed gradual accumulation of HS between 2 and 4 months of age, but full manifestation of microgliosis/astrogliosis as early as 2 months. Late HSCGT fully reversed the somatic symptoms, thus achieving the same degree of peripheral correction as early therapy. However, late treatment resulted in slightly decreased efficacy in the CNS, with poorer brain enzymatic activity, together with reduced normalization of HS oversulfation. Overall, our findings confirm significant lysosomal burden and neuropathology in 2-month-old MPSII mice. Peripheral disease is readily reversible by LV.IDS-HSCGT regardless of age of transplant, suggesting a viable treatment for somatic disease. However, in the brain, higher IDS enzyme levels are achievable with early HSCGT treatment, and later transplant seems to be less effective, supporting the view that the earlier patients are diagnosed and treated, the better the therapy outcome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mucopolysaccharidosis IIMedically Unexplained SymptomsIduronate SulfataseNervous System DiseasesHumansChildMiceAnimalsInfantHeparan SulfateGenetic TherapyStem Cells

Stichwörter der Autor:innen

Hunter diseasegene therapyhematopoietic stem cell gene therapylysosomalmucopolysaccharidosisreversibility

Substanzen

Iduronate SulfataseHeparan Sulfate

Autor:innen und Institutionen

  • Stem Cell and Neurotherapies, Division of Cell Matrix Biology and Regenerative Medicine, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

ORCID-Profile: Brian W Bigger

Zitieren

APA

Mandolfo, O., Liao, A., Singh, E., O'leary, C., Holley, R. J., & Bigger, B. W. (2024). Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease. Human Gene Therapy. https://doi.org/10.1089/hum.2023.002

Vancouver

Mandolfo O, Liao A, Singh E, O'leary C, Holley RJ, Bigger BW. Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease. Human Gene Therapy. 2024. doi:10.1089/hum.2023.002

BibTeX
@article{Mandolfo2024,
  author = {Mandolfo, Oriana and Liao, Aiyin and Singh, Esha and O'leary, Claire and Holley, Rebecca J and Bigger, Brian W},
  title = {Establishment of the Effectiveness of Early Versus Late Stem Cell Gene Therapy in Mucopolysaccharidosis II for Treating Central Versus Peripheral Disease},
  journal = {Human Gene Therapy},
  year = {2024},
  doi = {10.1089/hum.2023.002}
}
Kostenlos starten →